Health and Life Sciences Committee. Advancing the ASEAN Post-2015 Health Development Agenda

Transcription

1 Health and Life Sciences Committee Advancing the ASEAN Post-2015 Health Development Agenda Introduction The US-ASEAN Business Council s Health and Life Sciences (HLS) Committee is comprised of multinational companies that span across healthcare sectors including medical-device and diagnostics, pharmaceuticals, consumer health and hygiene, health systems strengthening and delivery of care, IT systems and nutrition. Co-chaired by GE Healthcare and Jhpiego, a non-profit organization that focuses on maternal and child health, and vice-chaired by GlaxoSmithKline, Johnson & Johnson and Merck Serono, the HLS Committee seeks to develop, in partnership with ASEAN governments and other stakeholders, sustainable models for health that provide all people with access to affordable, innovative, and quality care. Collectively, the members of the HLS Committee bring both breadth and depth of experience and expertise in areas across the health care value chain. HLS Committee members can bring new perspectives and ideas based on trends and developments in their respective fields on building health system sustainability and exploring new possibilities in regional cooperation on important health priorities. Having provided capacity-building, training, and counsel to policymakers both in ASEAN Member States (AMS) and around the world, the HLS Committee believes that we have much to offer as ASEAN embarks on realizing the goals outlined in the ASEAN Post-2015 Health Development Agenda, each of which are crucial in realizing a number of the 17 Sustainable Development Goals (SDGs) recently adopted by the UN General Assembly in September In turn, by engaging with AMS and understanding the priorities of AMS health ministries, industry can better respond to the most pressing health needs of ASEAN citizens. Members of the Health & Life Sciences Committee 1. 3M 2. Abbott Laboratories 3. AbbVie 4. Amgen 5. APCO Worldwide 6. AstraZeneca 7. Baxter 8. Becton, Dickinson and Company 9. Boston Scientific 10. Cigna 11. Eli Lilly and Company 12. GE 13. Gilead 14. GlaxoSmithKline 15. Jhpiego 16. Johnson & Johnson 17. Marsh & McLennan Companies 18. Mead Johnson Nutrition 19. Medtronic 20. MSD 21. Merck Serono 22. Novartis 23. P&G 24. Pfizer 25. Sanofi 26. Smiths Group

2 Advancing the ASEAN Post-2015 Health Development Agenda The members of the Health & Life Sciences (HLS) Committee would like to commend ASEAN for its commitment to the goals outlined in the ASEAN Post-2015 Health Development Agenda which addresses critical challenges faced in the region. Not only do these goals build a healthy, caring, and sustainable ASEAN Community, they also bring ASEAN closer to achieving many of the historic SDGs adopted at the 70 th United Nations General Assembly this year. These shared goals include the reduction of mortality from non-communicable diseases through prevention, treatment and the promotion of mental health and well-being; the pursuit of universal access to essential health care and achievement of universal health coverage; as well as the promotion of resilient health systems in response to communicable diseases, emerging infectious diseases, and neglected tropical diseases. Our members have committed strong action to advance these global SDGs through public-private partnerships around the world. Likewise, we would like to express our support and commitment to working closely with the ASEAN Secretariat and all ASEAN Member States Ministries of Health through enduring collaborative partnership on initiatives and regular dialogue to achieve these goals. In line with this commitment, the Council and its HLS Committee would like to offer our support whether in the form of a dialogue, best practice sharing, joint project, or other form of collaboration in advancing some of the health priorities outlined in the ASEAN Post-2015 Health Development Agenda. We have detailed the specific health priorities and examples of how we can be supportive in advancing them in the Appendix. Ongoing Dialogue with the ASEAN Senior Officials Meeting on Health Development (SOMHD) The Council and its HLS Committee would like to propose continuing this dialogue with the Senior Officials on Health Development (SOMHD) to arrive at concrete proposals to advance ASEAN health priorities. We propose framing this ongoing dialogue around the following broad topics: The role of Public-Private Partnerships (PPPs) in building sustainable healthcare systems 1. Global best practices in implementing PPPs 2. Recommendations for PPP implementation in ASEAN countries 3. Ways in which PPPs can help advance health priorities outlined in the ASEAN Post-2015 Health Development Agenda While this discussion may begin more broadly, we hope that this ongoing dialogue will lead to collaboration that will advance specific items on the ASEAN Post-2015 Health Development Agenda. The HLS Committee would welcome further discussions on our proposal with the ASEAN SOMHD, and would be happy to prepare a paper on these topics in advance.

3 Appendix Advancing the ASEAN Post-2015 Health Development Agenda We have highlighted in yellow specific health priorities in which US-ABC Health & Life Sciences Committee members have expertise and experience supporting in ASEAN and other parts of the world. The examples listed here are by no means exhaustive. Cluster Goal 2020 Health priorities How US-ABC HLS members can support 1. Promoting healthy lifestyle a) To achieve maximal health potential of ASEAN Community through promoting healthy lifestyle b) To ensure healthy lives and promote wellbeing for all at all ages i. Prevention and control of NCDs Our members have a strong history of collaboration with NGOs and governments in advancing the prevention and control of NCDs, for instance in communicating disease awareness of and education on the various NCDs. Capacity-building with primary health care-givers, which alleviate burdens such as hospital overcrowding, is another example of the many initiatives undertaken by HLS members. NCDs impact the length of life, quality of life, and health care spending. HLS members would be happy to discuss the role of effective referral pathways in improving care (hub and spoke models), and the role of improved health care infrastructure in enhancing care delivery and increasing health system efficiency. ii. Reduction of tobacco consumption and harmful use of alcohol iii. Prevention of injuries Our members are committed to reducing road-related injuries in AMS, for example through the distribution of helmets to children. iv. Promotion of occupational HLS members have contributed in developing and crafting best health practices in the APEC Healthy Women Toolkit, creating policy recommendations to improve workplace health and safety. v. Promotion of mental health HLS members have spearheaded numerous PPPs and thought leadership activities in the area of mental health, partnering with governments and NGOs in various countries. Examples include the training of care-givers/family members of patients, mental health awareness campaigns, job placement for patients, and the establishment of mental health information systems, including developing necessary protocols for ensuring patient-doctor confidentiality.

4 2. Health system response to all hazards and emerging threats a) To promote resilient health system in response to communicable diseases, emerging infectious diseases, and neglected tropical diseases b) To respond to environmental health threats, hazards and disaster, and to ensure effective preparedness for disaster health management in the region vi. Promotion of healthy and active ageing vii. Promotion of good nutrition and healthy diet viii. Prevention and control of communicable diseases, emerging infectious diseases and neglected tropical diseases ix. Strengthening laboratory capacity x. Combating antimicrobial resistance(amr) Through the APEC Healthy Women Toolkit, HLS members have developed educational campaigns on lifestyle-related diseases, training packages for health practitioners in nutrition and lifestyle and integrated awareness of nutritional health into governmental health strategies. Our members have a strong history of initiatives, including partnerships with NGOs, in communicating disease awareness and education on disease areas such as TB and HIV. HLS members also helped secure financing to strengthen community engagement in fighting TB, access to treatment for multi-drug resistant TB, lower the prices of first-line treatment drugs for HIV/AIDS and are in the process of providing low-cost Hepatitis C treatment. HLS members have also conducted parasitological examinations in schools and provided deworming treatments. In addition, HLS members are committed to addressing infection prevention and control issues (IPC) and reducing healthcare associated infections (HAIs) in ASEAN. Our members have partnered with healthcare providers around the world to enhance patient safety and delivery of care by organizing educational programs and creating partnerships that focus on building the capacity and capability of healthcare providers. One example is the creation of an educational toolkit that aims to enhance processes in healthcare facilities so as to reduce HAIs. HLS members have implemented successful PPPs in strengthening laboratory capacity. One example is a collaboration with the U.S. Agency for International Development (USAID) to strengthen Indonesia s national reference laboratory systems, in support of the National Tuberculosis (TB) Program (NTP). AMR is a serious issue facing many countries in the region and the global community. Effectively addressing AMR requires a focus on infection prevention; accurate diagnosis (to avoid inappropriate

5 3. Access to care a) ASEAN Community has universal access to [essential] health care, safe and good quality medical products including traditional and complementary medicines b) To achieve the unfinished health related MDGs, in light of the sustainable development goals (SDG) xi. Environmental health and health impact assessment (HIA) xii. Disaster Health Management xiii. Traditional Medicine xiv. Health related MDGs (4, 5, 6) xv. Universal health coverage (UHC) antibiotic use); antibiotic stewardship; and surveillance. The HLS Committee can be an effective knowledge partner in these areas. HLS members are invested in improving the quality of midwifery schools/colleges, and have provided training for currently practicing midwives using state-of-the-art training approaches. HLS members have contributed in developing and crafting best practices in the APEC Healthy Women Toolkit, aiming to boost maternal health and nutrition substantially, improve sexual and reproductive health and increasing women s financial access to health. HLS members also helped secure financing to strengthen community engagement in fighting TB, access to treatment for multi-drug resistant TB and lowered the prices of firstline treatment drugs for HIV/AIDS. HLS members have advised payers including governments and insurers on health technology assessments and reimbursement policies and practices, and can share these insights with AMS. xvi. Migrants health xvii. Pharmaceutical development viii. Human Resources Development xix. Health Financing HLS members have established partnerships with academic institutions to provide opportunities for pharmaceutical undergraduates to be exposed to the pharmaceutical industry. HLS members are committed to the training and development of health care worker expertise, particularly through centers of excellence established by industry partners. Members have also partnered with governments and leading academic institutions in ASEAN to open hospital management programs. HLS members have experience facilitating dialogue and providing counsel to countries undergoing health reform including health financing reform. Both collectively and individually, HLS members have

6 4. Food safety a) To promote access to safe food, safe drinking water and sanitation xx. Food safety a strong network of experts and awareness of the requirements of emerging health systems. One example of an area that members can provide insight into is that of outcomes-based incentives. Members can share such best practices and insights with AMS introducing the principles of evidence-based decision making, health economics, and alternative access and business strategies as a tool to balance access to innovation while ensuring efficient budget management. Our members are active participants in the food safety dialogue. Some examples include training of food safety officials in lab testing methods via AOAC SPIFAN Stakeholder Panel on Infant Formula and Adult Nutrition.